OLED microdisplay maker eMagin reported its financial results for Q3 2021. Revenues were $5.8 million in the quarter, down from $7.3 million in Q3 2021. Operating loss in the quarter was $3.3 million (down from $1.9 million in Q2 2021).

eMagin SXGA OLED-XL microdisplay photo

eMagin says that during the quarter it continued to grow its ENVG-B program revenues and also its medical customer revenues, but in total its revenues decreased due to timing issues of certain military orders, and also $1.3 million in shipments were delayed to Q4 due to to production issues and unexpected manufacturing tool downtime.

At the end of the quarter, eMagin's sales backlog grew to $14.9 million (up from $10.3 million at the end of Q2 2021). eMagin says it is experiencing raw material pricing pressures, and the company is working to manage potential changes in allocation from vendors due to supply chain issues in the semiconductor industry.

During the past quarter, eMagin unveiled a 10,000 nits dPd microdisplay prototype, and we reported on that. The company now says that in addition to that, it has completed the manufacturing qualification process for its high-luminance and power-efficient XLE displays in September. eMagin began to ramp production to meet customer demand. Its current XLE displays are qualified at over 1,500 cd/m2 and are already included in a major design with a military customer. These displays use eMagin’s existing backplane and are compatible with designs used by many customers, thereby providing an upgrade in luminance levels.

Notice: the author of this posts holds some shares at eMagin

Merck - Advancing Display, Advancing LifeMerck - Advancing Display, Advancing Life